217 related articles for article (PubMed ID: 31395362)
1. Reviewing the Demographic, Prognostic, and Treatment Factors of Primary Adenocarcinoma of the Bladder: A SEER Population-based Study.
Natale C; Leinwand GZ; Chiang J; Silberstein JL; Krane LS
Clin Genitourin Cancer; 2019 Oct; 17(5):380-388. PubMed ID: 31395362
[TBL] [Abstract][Full Text] [Related]
2. Contemporary rates of pathological features and mortality for adenocarcinoma of the urinary bladder in the USA.
Zaffuto E; Gazdovich S; Leyh-Bannurah SR; Huland H; Abdollah F; Shariat SF; Menon M; Briganti A; Montorsi F; Karakiewicz PI
Int J Urol; 2017 Feb; 24(2):117-123. PubMed ID: 27875858
[TBL] [Abstract][Full Text] [Related]
3. Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas.
Zhou YW; Long YX; Song K; Liang LB; Cheng K; Chen Y; Liu JY
Cancer Med; 2021 Aug; 10(16):5415-5428. PubMed ID: 34278741
[TBL] [Abstract][Full Text] [Related]
4. Effect of tumor location on survival in urinary bladder adenocarcinoma: A population-based analysis.
Dutta R; Abdelhalim A; Martin JW; Vernez SL; Faltas B; Lotan Y; Youssef RF
Urol Oncol; 2016 Dec; 34(12):531.e1-531.e6. PubMed ID: 27427223
[TBL] [Abstract][Full Text] [Related]
5. Survival in signet ring cell carcinoma varies based on primary tumor location: a Surveillance, Epidemiology, and End Results database analysis.
Wu SG; Chen XT; Zhang WW; Sun JY; Li FY; He ZY; Pei XQ; Lin Q
Expert Rev Gastroenterol Hepatol; 2018 Feb; 12(2):209-214. PubMed ID: 29227748
[TBL] [Abstract][Full Text] [Related]
6. Clinical features, treatment, and prognosis of different histological types of primary small bowel adenocarcinoma: A propensity score matching analysis based on the SEER database.
Zhou YW; Xia RL; Chen YY; Ma XL; Liu JY
Eur J Surg Oncol; 2021 Aug; 47(8):2108-2118. PubMed ID: 33849741
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Epidemiological Factors and Treatment Interventions on Survival in Patients With Signet Ring Cell Carcinoma of the Pancreas.
Patel M; Hans HS; Pan K; Khan H; Donath E; Caldera H
Am J Clin Oncol; 2018 Dec; 41(12):1176-1184. PubMed ID: 29672365
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of signet ring cell histology in esophageal adenocarcinoma.
Yendamuri S; Huang M; Malhotra U; Warren GW; Bogner PN; Nwogu CE; Groman A; Demmy TL
Cancer; 2013 Sep; 119(17):3156-61. PubMed ID: 23719932
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study.
Cattrini C; Cerbone L; Rubagotti A; Zinoli L; Latocca MM; Messina C; Zanardi E; Boccardo F
Clin Genitourin Cancer; 2019 Aug; 17(4):e724-e732. PubMed ID: 31160193
[TBL] [Abstract][Full Text] [Related]
10. The impact of signet-ring cell carcinoma histology on bladder cancer outcome.
Wang J; Wang FW; Kessinger A
World J Urol; 2012 Dec; 30(6):777-83. PubMed ID: 21706144
[TBL] [Abstract][Full Text] [Related]
11. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder.
Wright JL; Porter MP; Li CI; Lange PH; Lin DW
Cancer; 2006 Aug; 107(4):721-8. PubMed ID: 16826584
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis.
Ackermann CJ; Guller U; Jochum W; Schmied BM; Warschkow R
Int J Colorectal Dis; 2018 Sep; 33(9):1183-1193. PubMed ID: 29881972
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Korean patients with clinically localized urachal or non-urachal adenocarcinoma of the bladder.
Cho SY; Moon KC; Park JH; Kwak C; Kim HH; Ku JH
Urol Oncol; 2013 Jan; 31(1):24-31. PubMed ID: 21458312
[TBL] [Abstract][Full Text] [Related]
14. A California Cancer Registry Analysis of Urothelial and Non-urothelial Bladder Cancer Subtypes: Epidemiology, Treatment, and Survival.
Martin JW; Jefferson FA; Huang M; Sung JM; Chang J; Piranviseh K; Ziogas A; Anton-Culver H; Youssef RF
Clin Genitourin Cancer; 2020 Jun; 18(3):e330-e336. PubMed ID: 32144047
[TBL] [Abstract][Full Text] [Related]
15. Squamous Cell Carcinoma of the Bladder: A SEER Database Analysis.
Abdel-Rahman O
Clin Genitourin Cancer; 2017 Jun; 15(3):e463-e468. PubMed ID: 27876505
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and outcomes of patients with primary signet-ring cell carcinoma of the urinary bladder.
Wang J; Wang FW
Urol Int; 2011; 86(4):453-60. PubMed ID: 21525723
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis.
Li Y; Feng Y; Dai W; Li Q; Cai S; Peng J
Clin Colorectal Cancer; 2019 Mar; 18(1):e104-e116. PubMed ID: 30448100
[TBL] [Abstract][Full Text] [Related]
18. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum.
Kang H; O'Connell JB; Maggard MA; Sack J; Ko CY
Dis Colon Rectum; 2005 Jun; 48(6):1161-8. PubMed ID: 15868237
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.
Thomas AA; Stephenson AJ; Campbell SC; Jones JS; Hansel DE
Hum Pathol; 2009 Jan; 40(1):108-16. PubMed ID: 18789486
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of leiomyosarcoma of the urinary bladder: analysis of 183 cases.
RodrÃguez D; Preston MA; Barrisford GW; Olumi AF; Feldman AS
Urol Oncol; 2014 Oct; 32(7):958-65. PubMed ID: 25027684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
